Rapid lateral flow test for Mycobacterium tuberculosis complex and non-tuberculous mycobacteria differentiation
-
Published:2024-09-02
Issue:1
Volume:108
Page:
-
ISSN:0175-7598
-
Container-title:Applied Microbiology and Biotechnology
-
language:en
-
Short-container-title:Appl Microbiol Biotechnol
Author:
Phunpae Ponrut, Thongkum Weeraya, Panyasit Wutthichai, Laopajon Witida, Takheaw Nuchjira, Pata Supansa, Yasamut Umpa, Kasinrerk Watchara, Tayapiwatana ChatchaiORCID
Abstract
Abstract
The diagnosis of mycobacterial infections, including both the Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM), poses a significant global medical challenge. This study proposes a novel approach using immunochromatographic (IC) strip tests for the simultaneous detection of MTBC and NTM. Traditional methods for identifying mycobacteria, such as culture techniques, are hindered by delays in distinguishing between MTBC and NTM, which can affect patient care and disease control. Molecular methods, while sensitive, are resource-intensive and unable to differentiate between live and dead bacteria. In this research, we developed unique monoclonal antibodies (mAbs) against Ag85B, a mycobacterial secretory protein, and successfully implemented IC strip tests named 8B and 9B. These strips demonstrated high concordance rates with conventional methods for detecting MTBC, with positivity rates of 93.9% and 85.9%, respectively. For NTM detection, the IC strip tests achieved a 63.2% detection rate compared to culture methods, considering variations in growth rates among different NTM species. Furthermore, this study highlights a significant finding regarding the potential of MPT64 and Ag85B proteins as markers for MTBC detection. In conclusion, our breakthrough method enables rapid and accurate detection of both MTBC and NTM bacteria within the BACTEC MGIT system. This approach represents a valuable tool in clinical settings for distinguishing between MTBC and NTM infections, thereby enhancing the management and control of mycobacterial diseases.
Key points
• Panel of mAbs for differentiating MTB versus NTM
• IC strips for diagnosing MTBC and NTM after the BACTEC MGIT
• Combined detection of MTP64 and Ag85B enhances diagnostic accuracy
Funder
Office of National Higher Education Science Research and Innovation Policy Council Chiang Mai University
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Anand AR, Biswas J (2021) TB or NTM: Can a new multiplex PCR assay be the answer? EBioMedicine 71:103552. https://doi.org/10.1016/j.ebiom.2021.103552 2. Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O’Brien C, O’Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA (2016) Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science 354:751–757. https://doi.org/10.1126/science.aaf8156 3. Caulfield AJ, Wengenack NL (2016) Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. J Clin Tuberc Other Mycobact Dis 4:33–43. https://doi.org/10.1016/j.jctube.2016.05.005 4. Chuensirikulchai K, Laopajon W, Phunpae P, Apiratmateekul N, Surinkaew S, Tayapiwatana C, Pata S, Kasinrerk W (2019) Sandwich antibody-based biosensor system for identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria. J Immunoassay Immunochem 40(6):590–604. https://doi.org/10.1080/15321819.2019.1659814 5. Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA (2020) Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis 71:e1–e36. https://doi.org/10.1093/cid/ciaa241
|
|